Catalog record · Operations & Efficiency
Stage as of Oct 1, 2026 · historical report, not live reconfirmation.
Aviva protection medical-evidence summarization
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 26, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
AI summarizes evidence for life, critical illness and income-protection underwriters, who retain final decisions.
- Reported stage
- Production
- Technology
- GenAI/LLM
- Business function
- Back Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 26, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
October 2026 account describes real underwriting use across three protection lines. Status as of 2026-10-01.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Deployment evidence does not establish measured effectiveness or independently validated ROI.
Source register
- From life cover to income protection: Lessons from scaling AI across protection underwritingconnect.avivab2b.co.uk · opens in a new tab
Aviva · issuer · full-text · Published 2026-10-01
Research lanes: life_health_insurance · Batch global-discovery-2026-10-26. Coverage and remaining gaps